| pubmed-article:8559498 | pubmed:abstractText | In recent years a reduction of oral cyclosporin A (CsA) dose has been adopted to minimize its adverse renal effects. To date, however, little is known about the intrinsic renal and immunological effects of low-dose CsA. | lld:pubmed |
